More growth announced today for the Indiana based healthcare system, NeuroPsychiatric Hospitals.
The hospital system is headquartered in South Bend, Indiana with a regional corporate office in Indianapolis. Founder and Chairman Cameron Gilbert, PhD announced a new hospital to their system, that began in 2005, and will now total five hospitals that focus on treating the most complex psychiatric patients who also suffer with significant medical and neurological disorders as well. “I am excited to announce we are expanding our Medical/Neuropsychiatric services to a new hospital in Houston, Texas. “Focusing on patient needs and our hospital system’s clinical strengths have been the driving factors for this expansion”, stated Dr. Gilbert. The hospital will contain 120 beds and will be named Medical Behavioral Hospital of Houston. According to Gilbert, the hospital is set to open in late 2019. Dr. Gilbert also stated “Stay tuned, more expansion hospitals will be announced soon as we take our mission of treating the most complex psychiatric patients with serious medical and neurological disorders throughout the US.”
NeuroPsychiatric Hospitals has officially OPENED the doors to NeuroBehavioral Hospital of Crown Point! NBH has 70 beds including four individualized, safe and specialized units. It truly is a state-of-the-art hospital.
An invitation to the open house at NeuroBehavioral Hospital is August 9th, we hope you can attend to see our newest addition. If you have any questions my contact information is below, please feel free to give me a call any time. If you have a big group attending let me know, or if you’d like to attend a different day.
NeuroPsychiatric Hospital of Indianapolis also has female and male beds available locally. We look forward to serving your needs and the needs of your client and patient.
Thank you for all your support!
IF YOU FEEL YOU MAY HAVE A REFERRAL DON’T WAIT LONG,
CALL THE 24/7 REFERRAL INTAKE HOTLINE NOW
- Ashraf SM, Williams SF, Al-Homsi AS, et al (2017). Retrospective review to evaluate the impact of PCP prophylaxis in plasma cell dyscrasia patients after autologous hematopoietic stem cell transplant. Biology of Blood and Marrow Transplant, 23(3), S132-S133. http://dx.doi.org/10.1016/j.bbmt.2016.12.247
- Bell J (2017). A retrospective analysis comparing discharge disposition to readmission rate in patients undergoing HPC transplant who experienced ICU stay. Biology of Blood and Marrow Transplant, 23(3), S469-S470. http://dx.doi.org/10.1016/j.bbmt.2016.12.557
NeuroBehavioral Hospital Press Release